Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Navigating Conflicting 2025 Dietary Guidelines for Metabolic Health

    October 10, 2026

    2025 Clinical Trials Breakthroughs: Key Insights for Medical Researchers

    October 9, 2026

    Navigating the 2025-2030 Dietary Guidelines for Cardiometabolic Prevention

    October 8, 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Health Magazine
    • Home
    • Environmental Health
    • Health Technology
    • Medical Research
    • Mental Health
    • Nutrition Science
    • Pharma
    • Public Health
    • Discover
      • Daily Health Tips
      • Financial Health & Stability
      • Holistic Health & Wellness
      • Mental Health
      • Nutrition & Dietary Trends
      • Professional & Personal Growth
    • Our Mission
    Health Magazine
    Home » News » Shaping the future of asthma management with NObreath® at ATS 2026
    Discover

    Shaping the future of asthma management with NObreath® at ATS 2026

    healthadminBy healthadminMay 11, 2026No Comments2 Mins Read
    Shaping the future of asthma management with NObreath® at ATS 2026
    Share
    Facebook Twitter Reddit Telegram Pinterest Email


    Bedfont® Scientific Ltd, a world leader in exhaled breath analysis, is pleased to be attending this year’s American Thoracic Society (ATS) International Conference and exhibiting its innovative NObreath® fractional exhaled nitric oxide (FeNO) device in booth 1236 with its US distributor coVita™. Bedfont® is an innovative MedTech company with nearly 50 years of expertise in the design and manufacturing of medical breath analyzers, helping to improve patient outcomes around the world.


    Image credit: Bedfont® Scientific Ltd.

    The ATS International Conference, held May 15th and 20th at the Orange County Convention Center in Orlando, Florida, is a global event bringing together more than 15,000 pulmonary, critical care and sleep medicine experts to share groundbreaking research and advance clinical practice. Bedfont® shares how NObreath® is revolutionizing asthma treatment around the world.

    The team will be located at booth 1236, where they will be showcasing NObreath®. NObreath® has helped improve asthma care and management for over 15 years by providing objective insight into airway inflammation, a key feature of asthma. This allows clinicians to measure inflammation non-invasively, supporting a future where today’s science meets tomorrow’s treatments.

    We are thrilled to be at ATS this year and bring our team of experts to the stand to engage with the global respiratory community. Attendees are encouraged to come and talk to us, experience our technology first-hand, and explore how we can collaborate. ATS provides an important platform to showcase NObreath® and its effectiveness in respiratory care. ”

    Jason Smith, Bedfont® CEO

    Joining Bedfont® and coVita™ at booth 1236 will be Carol Stonham MBE, member of the Medical Advisory Board. He is a respiratory specialist and Clinical Lead for Children and Young People’s Asthma at Gloucestershire ICB. Carol brings a wealth of knowledge to the event and will be hosting a talk at Innovation Hub 3 on Sunday, May 17th at 1:15pm EDT. There she explores the role of FeNO in practice and discusses emerging issues.
    chance.

    The Bedfont® team will be on display at booth 1236 from May 17th to 19th. For more information, please visit this website.



    Source link

    Visited 15 times, 1 visit(s) today
    Share. Facebook Twitter Pinterest LinkedIn Telegram Reddit Email
    Previous ArticleSignificant reduction in ‘permanent chemicals’ in seabird eggs hailed as regulatory victory | Pfas
    Next Article Eli Lilly taps health theme in new Caitlin Clark ad campaign
    healthadmin

    Related Posts

    Texas A&M researchers build AI tool for tuberculosis drug discovery

    July 30, 2026

    New ultrasound technology breaks blood-brain barrier to treat gliomas

    July 30, 2026

    Omalizumab wins multi-allergen oral immunotherapy in multi-food allergy trial

    July 30, 2026

    MAGFLO™ NGS beads: cost-effective nucleic acid purification

    July 30, 2026

    Qureight completes $20 million Series B funding

    July 30, 2026

    Cigarette smoke extract stimulates airway cells and increases nanoplastic damage

    July 30, 2026
    Add A Comment

    Comments are closed.

    Categories

    • Daily Health Tips
    • Discover
    • Environmental Health
    • Exercise & Fitness
    • Featured
    • Featured Videos
    • Financial Health & Stability
    • Fitness
    • Fitness Updates
    • Health
    • Health Technology
    • Healthy Aging
    • Healthy Living
    • Holistic Healing
    • Holistic Health & Wellness
    • Medical Research
    • Medical Research & Insights
    • Mental Health
    • Mental Wellness
    • Natural Remedies
    • New Workouts
    • Nutrition
    • Nutrition & Dietary Trends
    • Nutrition & Superfoods
    • Nutrition Science
    • Pharma
    • Preventive Healthcare
    • Professional & Personal Growth
    • Public Health
    • Public Health & Awareness
    • Selected
    • Sleep & Recovery
    • Top Programs
    • Weight Management
    • Workouts
    Popular Posts
    • 1773313737_bacteria_-_Sebastian_Kaulitzki_46826fb7971649bfaca04a9b4cef3309-620x480.jpgHow Sino Biological ProPure™ redefines ultra-low… March 12, 2026
    • pexels-david-bartus-442116The food industry needs to act now to cut greenhouse… January 2, 2022
    • 1773729862_TagImage-3347-458389964760995353448-620x480.jpgDespite safety concerns, parents underestimate the… March 17, 2026
    • 1774403998_image_28620e4b6b0047f7ab9154b41d739db1-620x480.jpgGait pattern helps distinguish between Lewy body… March 24, 2026
    • 1773209206_futuristic_techno_design_on_background_of_supercomputer_data_center_-_Image_-_Timofeev_Vladimir_M1_4.jpegMulti-agent AI systems outperform single models… March 11, 2026
    • Leukemia-620x480.jpgBiomimetic platform powers CAR T therapy for… March 9, 2026

    Demo
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss

    Navigating Conflicting 2025 Dietary Guidelines for Metabolic Health

    By healthadminOctober 10, 2026

    Specialists face inconsistencies in applying 2025 dietary guidelines to metabolic health. Explore evidence on protein levels, bioactive compounds, and personalized nutrition interventions.

    2025 Clinical Trials Breakthroughs: Key Insights for Medical Researchers

    October 9, 2026

    Navigating the 2025-2030 Dietary Guidelines for Cardiometabolic Prevention

    October 8, 2026

    The Digital Health Challenge Facing Founders and Engineers in 2026

    October 7, 2026

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    HealthxMagazine
    HealthxMagazine

    At HealthX Magazine, we are dedicated to empowering entrepreneurs, doctors, chiropractors, healthcare professionals, personal trainers, executives, thought leaders, and anyone striving for optimal health.

    Our Picks

    The Digital Health Challenge Facing Founders and Engineers in 2026

    October 7, 2026

    The Mental Health Crisis: What Psychiatrists and Policymakers Must Address Now

    October 6, 2026

    Navigating the Flood of New Clinical Trial Data

    October 5, 2026
    New Comments
      Facebook X (Twitter) Instagram Pinterest
      • Home
      • Privacy Policy
      • Our Mission
      © 2026 ThemeSphere. Designed by ThemeSphere.

      Type above and press Enter to search. Press Esc to cancel.